Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients

INTRODUCTION: Since treatment modalities for metastatic recurrent triple-negative breast cancer (mrTNBC) are limited, a novel treatment approach including immunotherapy is required. We have developed a novel regimen of personalized peptide vaccination (PPV), in which vaccine antigens are individuall...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryuji, Toh, Uhi, Iwakuma, Nobutaka, Takenaka, Miki, Otsuka, Hiroko, Furukawa, Mina, Fujii, Teruhiko, Seki, Naoko, Kawahara, Akihiko, Kage, Masayoshi, Matsueda, Satoko, Akagi, Yoshito, Yamada, Akira, Itoh, Kyogo, Sasada, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227005/
https://www.ncbi.nlm.nih.gov/pubmed/24992895
http://dx.doi.org/10.1186/bcr3685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227005/
https://www.ncbi.nlm.nih.gov/pubmed/24992895
http://dx.doi.org/10.1186/bcr3685

Ejemplares similares